Showing results 2 to 4 of 4
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
How mental health care should change as a consequence of the COVID-19 pandemic Journal:The Lancet Psychiatry | 2020 | ||
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection Journal:New England Journal of Medicine | 2015 | ||
Sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks in genotype 1, 2, 4, 5, 6 HCV patients: ASTRAL-1 study Proceeding/Conference:Hepatology International | 2016 |